title: Ivabradine versus bisoprolol.
authors.forename: G
authors.initials: G
authors.lastname: Fazio
authors.forename: F
authors.initials: F
authors.lastname: Sarulo
authors.forename: P
authors.initials: P
authors.lastname: Licata
authors.forename: L
authors.initials: L
authors.lastname: D'Angelo
authors.forename: S
authors.initials: S
authors.lastname: Passantino
authors.forename: C
authors.initials: C
authors.lastname: Visconti
authors.forename: P
authors.initials: P
authors.lastname: Zarcone
authors.forename: C
authors.initials: C
authors.lastname: Spanò
authors.forename: G
authors.initials: G
authors.lastname: Novo
authors.forename: S
authors.initials: S
authors.lastname: Novo
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001552:Benzazepines / Q000627:therapeutic use*; D017298:Bisoprolol / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D000077550:Ivabradine; D008297:Male; D008875:Middle Aged
chemical_list: D000319:Adrenergic beta-Antagonists; D001552:Benzazepines; D000077550:Ivabradine; D017298:Bisoprolol